MetLife Investment Management’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.63M Sell
65,910
-528,163
-89% -$12.6M 0.01% 1166
2025
Q4
$13.9M Sell
594,073
-145,595
-20% -$3.24M 0.07% 267
2025
Q3
$14.6M Buy
739,668
+156,947
+27% +$3.23M 0.07% 259
2025
Q2
$12.6M Sell
582,721
-141,370
-20% -$3.34M 0.07% 254
2025
Q1
$17.6M Buy
724,091
+656,004
+963% +$14.8M 0.09% 182
2024
Q4
$1.42M Buy
68,087
+4,413
+7% +$94.8K 0.01% 1241
2024
Q3
$1.27M Sell
63,674
-3,663
-5% -$67.9K 0.01% 1259
2024
Q2
$1.04M Buy
67,337
+10,323
+18% +$161K 0.01% 1320
2024
Q1
$909K Buy
57,014
+4,814
+9% +$72.5K 0.01% 1349
2023
Q4
$877K Hold
52,200
0.01% 1369
2023
Q3
$610K Hold
52,200
﹤0.01% 1507
2023
Q2
$702K Buy
52,200
+1,716
+3% +$24.7K 0.01% 1476
2023
Q1
$837K Hold
50,484
0.01% 1322
2022
Q4
$939K Sell
50,484
-2,610
-5% -$40.2K 0.01% 1253
2022
Q3
$681K Hold
53,094
0.01% 1411
2022
Q2
$372K Buy
53,094
+3,747
+8% +$27.5K ﹤0.01% 1866
2022
Q1
$409K Buy
49,347
+14,017
+40% +$99.1K ﹤0.01% 1897
2021
Q4
$239K Buy
35,330
+9,632
+37% +$63.3K ﹤0.01% 1951
2021
Q3
$136K Sell
25,698
-16,522
-39% -$90.3K ﹤0.01% 2296
2021
Q2
$243K Hold
42,220
﹤0.01% 2034
2021
Q1
$195K Buy
42,220
+25,452
+152% +$101K ﹤0.01% 2065
2020
Q4
$56K Sell
16,768
-3,038
-15% -$10.2K ﹤0.01% 2252
2020
Q3
$58.8K Sell
19,806
-26,001
-57% -$102K ﹤0.01% 2262
2020
Q2
$212K Hold
45,807
﹤0.01% 1876
2020
Q1
$176K Buy
45,807
+20,495
+81% +$84.1K ﹤0.01% 1772
2019
Q4
$94.9K Sell
25,312
-23,931
-49% -$112K ﹤0.01% 2270
2019
Q3
$261K Hold
49,243
﹤0.01% 1791
2019
Q2
$189K Hold
49,243
﹤0.01% 2060
2019
Q1
$251K Hold
49,243
﹤0.01% 1850
2018
Q4
$94.5K Hold
49,243
﹤0.01% 2311
2018
Q3
$186K Sell
49,243
-1,106
-2% -$3.46K ﹤0.01% 2130
2018
Q2
$157K Buy
+50,349
New +$153K ﹤0.01% 2028
2018
Q1
Sell
-36,877
Closed -$144K 2205
2017
Q4
$144K Buy
+36,877
New +$122K ﹤0.01% 2091

Other funds holding CPRX